Last update:
Genetics news
Genetics
Genetic discovery could lead to better prediction of suicide risk within families
Every 11 minutes, an American dies by suicide. That's 132 people a day or more than 48,000 annually. For those left behind, the haunting question is why.
Nov 26, 2020
0
39
Genetics
Study identifies new functions in the gene that causes Machado-Joseph disease
Ataxia is a minority disease with genetic origins, known for its neuromuscular alterations due to the selective loss of neurons in the cerebellum, the organ of our nervous systems which controls movement and balance. UB researchers ...
Nov 25, 2020
0
13
Researchers reveal how genetic variations are linked to COVID-19 disease severity
Even as tens of thousands of Americans test positive for COVID-19 each day, physicians still aren't sure why some people experience mild to no symptoms while others become critically ill. New research led by Robert E. Gerszten, ...
Nov 25, 2020
0
16
The genetics of side-effects
Henk-Jan Guchelaar knows all too well the serious problems that the side-effects of medication can cause. As a professor of clinical pharmacy at the University of Leiden in the Netherlands, he has spent the last two decades ...
Nov 25, 2020
0
3
Gene donors at high risk for cancer received feedback
Researchers at the Estonian Genome Center at the University of Tartu studied how people at high risk for breast, ovarian or prostate cancer responded to the feedback of genetic findings. Gene donors who chose to receive results ...
Nov 25, 2020
0
2
BICRA gene provides answers to patients, doctors and scientists
Physicians and scientists are constantly on the lookout for new disease genes that can help them understand why patients have undiagnosed medical problems. Often the first clues come from genetic testing that reveals a change ...
Nov 23, 2020
0
42
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical ...
Nov 23, 2020
0
24
Targeting drug-resistant cancers through mathematical biology to control gene expression
Among the things to give thanks for this year is the fact that stubborn, persistent problems seem to have an irresistible sort of magnetic pull for scientists and mathematicians. Things that would leave most of us bewildered ...
Nov 23, 2020
0
35
Major new study unveils complexity and vast diversity of Africa's genetic variation
Africa is the cradle of humankind. All humans are descendants from this common pool of ancestors. Africa and its multitude of ethnolinguistic groups are therefore fundamental to learning more about humankind and our origins.
Nov 23, 2020
0
2
Study finds hyperbaric oxygen treatments reverse aging process
A new study from Tel Aviv University (TAU) and the Shamir Medical Center in Israel indicates that hyperbaric oxygen treatments (HBOT) in healthy aging adults can stop the aging of blood cells and reverse the aging process. ...
Nov 20, 2020
9
1075
Children's Hospital Los Angeles conducts largest pediatric genomic COVID-19 study to date
When it comes to children, it is becoming clear that COVID-19 impacts them more than was initially realized. Yet there is relatively little information about SARS-CoV-2, the virus that causes the disease, in pediatric populations. ...
Nov 20, 2020
0
4
A gene mutation that protects against disease
Canadian scientists looking at a rare genetic mutation think they may have discovered the proverbial fountain of youth. But it's not for everyone: so far, the mutation has only been found in a handful of French-Canadian families.
Nov 19, 2020
0
5
CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder. Scientists from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Max Delbrück Center für ...
Nov 19, 2020
0
6
Revolutionary CRISPR-based genome editing system treatment destroys cancer cells
Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer. The researchers developed ...
Nov 18, 2020
0
5790
Found: A genetic link to molecular events that precede symptoms in Alzheimer's disease
Researchers at Tufts University School of Medicine have discovered a molecular mechanism that causes a "traffic jam" of enzymes traveling up and down neuronal axons, leading to the accumulation of amyloid beta—a key feature ...
Nov 18, 2020
0
144
Gene could slow down tumor repair in breast cancer brain metastasis
Treating tumors presents a tricky conundrum: a higher dose of radiation is more effective for treatment, but the higher the dose, the more danger it poses to healthy cells.
Nov 18, 2020
0
23
Proteogenomics enhances the identification of therapeutic vulnerabilities in breast cancer
Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity of breast cancer. With ...
Nov 18, 2020
0
4
Gene therapy startup to increase AAV gene therapy efficiency
Maximizing the efficiency of the adeno-associated virus (AAV) platform for gene therapy is the aim of a new pilot project of the National Institutes of Health (NIH). The NIH Platform Vector Gene Therapy (PaVe-GT) project ...
Nov 18, 2020
0
2
Non-hereditary mutation acts as natural gene therapy in patient with rare disease
Researchers affiliated with the Center for Cell-Based Therapy (CTC (http://ctcusp.org/rationale-2/presentation)) in Ribeirão Preto, Brazil, have identified for the first time a non-hereditary mutation in blood cells from ...
Nov 17, 2020
0
1
Screening younger women for hereditary cancers may be cost effective
Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost effective in women between the ages of 20 and 35, according to a study published in JAMA Network Open.
Nov 16, 2020
0
5
